STRATA Skin Sciences Announces Approval of XTRAC Momentum™ 1.0 Device in Japan

July 23, 2024

https://www.globenewswire.com/news-release/2024/07/22/2916495/23161/en/STRATA-Skin-Sciences-Announces-Approval-of-XTRAC-Momentum-1-0-Device-in-Japan.html

HORSHAM, Penn., July 22, 2024 (GLOBE NEWSWIRE) — STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces the approval of its XTRAC Momentum™ 1.0 device by the Ministry of Health, Labor and Welfare of Japan. The Company initially launched the XTRAC Momentum™ in the U.S. in early 2022. The immediate commercial rollout of the device in Japan will be through JMEC Co., Ltd., the Company’s longstanding Japanese strategic partner and distributor. STRATA’s excimer devices are currently used by over 300 hospitals and private practice dermatology clinics in Japan.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.